Home > Press > Premier Healthcare Pitch Competition comes to Atlanta this May
Abstract:
Round2Funding invites early stage healthcare Companies to apply for THE MAIN EVENT to be held May 17th at the Georgia Tech Conference Center. Companies will have the opportunity to present to medical experts, industry professionals, successful healthcare entrepreneurs and Investors. All finalists will be invited to join Round2Funding, an invitation-only investment portal directly connecting accredited Investors and vetted healthcare Companies. Round2Funding focuses on healthcare startups seeking $1 to $5 million in investments and allows Investors to anonymously evaluate these vetted healthcare Companies.
"Raising capital can be a daunting and strenuous process, but it does not have to be," says Chris Fair, founder and President of Round2Funding, Inc. "By providing companies with the correct tools to successfully raise capital and connect them with the right Investors, the fundraising process can be seamless."
According to the Wall Street Journal, "[medical startup and biotechnology] first round financing is on pace to reach $259.73 million this year, less than half the amount in 2007 and down 21% from last year." Companies are now turning to family offices and high net worth individuals for funding. Companies however, have a hard time finding Family Offices and individual Investors. Mr. Fair knew there was an opportunity to capitalize on the healthcare Companies not just in Southeast, but across the globe.
Round2Funding's Investor network is targeted towards Family Offices, high net worth individuals, and large angel groups. Round2Funding Investors are looking to invest in healthcare startups transitioning from product validation to commercialization. Round2Funding seeks to simplify the match making process by providing Investors with a secure portal to view healthcare startups while maintaining their anonymity.
"With little effort on our end, Round2Funding enables us to review deal flow we may not find on our own while keeping our identity private," says Will Loving, Altron Investments.
Round2Funding is now accepting applications for The MAIN EVENT at www.round2funding.com/main-event.
####
About Round2Funding, Inc.
Round2Funding is an invitation-only investment portal that directly connects vetted healthcare Companies with accredited Investors. Round2Funding was created to address the needs of early stage healthcare Companies attempting to raise capital and investment institutions looking to invest directly in quality, vetted healthcare opportunities. Round2Funding aims to provide a credible alternative to the current broker dealer model.
For more information, please click here
Contacts:
Chakshu Mehta
770-235-4895
Chakshu Mehta
Project Manager
MEDTOWN Ventures
(770) 235-4895 Cell
(855) MEDTOWN (633-8696)
www.medtownventures.com
Copyright © Round2Funding, Inc.
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
VC/Funding/Angel financing/Loans/Leases/Crowdfunding
Graphene Flagship start-up Bedimensional closes a second €10 million investment round February 10th, 2023
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Events/Classes
A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024
Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||